Diagnosis and Management of Homozygous Familial Hypercholesterolemia is organized by Healio.
Release Date: November 30, 2023
Expiration Date: November 30, 2024
Activity Description
Interact and learn alongside virtual patients and physicians as you practice managing children and adults with HoFH. This platform allows participants to work through real-life clinical scenarios in a stress-free environment with expert guidance and mentorship throughout each case scenario. Expert faculty will review the pathogenesis of HoFH, symptoms, diagnosis, guideline-based cascade screening, and the latest data for approved and evidence-based management for HoFH. An emphasis on strategies to individualize therapy depending on genetics and a patient's response to therapy is applied throughout the simulation to ensure patients are receiving the most appropriate management for their disease.
Learning Objectives:
Upon successful completion of this activity, participants should be better able to:
• Implement strategies for the timely diagnosis of HoFH
• Discuss the role of cascade screening in identifying patients with HoFH
• Integrate current approved therapies for the treatment of HoFH
• Individualize treatment for patients with HoFH based on response to therapy and/or disease genetics